Tackling mPDAC: chemotherapy strategies that matter

May 19, 2025 • 00:21:51
Tackling mPDAC: chemotherapy strategies that matter
COR2ED - Oncology Medical Conversation
Tackling mPDAC: chemotherapy strategies that matter

May 19 2025 | 00:21:51

/

Show Notes

Metastatic pancreatic ductal adenocarcinoma (mPDAC) is notoriously aggressive with a poor prognosis. It is often diagnosed late, and by this time, surgery is usually not an option. Median overall survival without treatment is just a few months but with systemic chemotherapy this can be improved.   

This video includes the highlights from a video podcast where medical oncologists Prof Shubham Pant and Prof Efrat Dotan discuss how to choose and optimise the different chemotherapeutic options at first and second line. 

Key clinical takeaways: 

You can also watch a video of the experts in conversation and download the accompanying transcript on our website: https://cor2ed.com/gi-connect/programmes/tackling-mpdac/?media=0 

Or watch on YouTube: https://youtu.be/8YxRnjOYUv4 

Follow us on social media: 

LinkedIn: https://www.linkedin.com/company/giconnect 

X: https://x.com/giconnectInfo 

This content is intended for healthcare professionals only. 

The medical experts in this podcast are expressing their own views and not those of COR2ED, Supporters or their institution.  This podcast is supported by an Independent Education Grant from Ipsen USA. 

This podcast is developed by cor2ed.com 

Published May 2025 

Subscribe to this channel to stay up to date with new Independent Education programmes as they’re released.

Other Episodes

Episode

December 06, 2023 • 00:22:49
Episode Cover

Prostate cancer: PARP inhibitors. Part 3 - Efficacy and safety of combination therapy

Dr Tanya Dorff, a Medical Oncologist from the City of Hope Comprehensive Cancer Center and Dr Neeraj Agarwal, Medical Oncologist and Director of the...

Listen

Episode

December 06, 2023 • 00:32:39
Episode Cover

Neuroendocrine tumours: The role of SSA at progression - To continue or not?

In this podcast, Prof. Martyn Caplin and Dr Aman Chauhan discuss the role of somatostatin analogues (SSAs) at progression and whether to continue or...

Listen

Episode

January 25, 2024 • 00:27:48
Episode Cover

Lung cancer: Pre-analytical phase challenges and biomarker testing

What are the common pre-analytical phase challenges in lung cancer, and how can we overcome them? Why is it important to identify genetic alterations?...

Listen